CONSORT Harms 2022 statement, explanation, and elaboration:updated guideline for the reporting of harms in randomised trials

(2023) CONSORT Harms 2022 statement, explanation, and elaboration:updated guideline for the reporting of harms in randomised trials. BMJ. e073725. ISSN 1756-1833

Metadata

Item Type: Article
Dates:
  • Published: 24 April 2023
  • Accepted: 6 February 2023
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 26 Apr 2023 09:40
Last Modified: 16 Oct 2024 19:10
Published Version: https://doi.org/10.1136/bmj-2022-073725
Status: Published
Refereed: Yes
Identification Number: 10.1136/bmj-2022-073725
Open Archives Initiative ID (OAI ID):

Download

Published Version

Filename: bmj_2022_073725.full.pdf

Description: CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

Licence: CC-BY-NC 2.5

CLICK TO DOWNLOAD [thumbnail of CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials]

Export

Statistics


CORE (COnnecting REpositories)